Form 4 for IMNM Immunome Inc.
Accepted 2026-06-09 17:40:12 ET · period of report 2026-06-05 · accession 0001221590-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-06-09 17:40 | 2026-06-05 | IMNM | BIENAIME JEAN JACQUES | Dir | S - Sale | $19.41 | -10.5K | 32.9K | -24% | -$203.8K |
| M | 2026-06-09 17:40 | 2026-06-05 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $19.45 | +10.5K | 43.4K | +32% | +$204.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | S | D | 500 | $19.44 | 42,915 | D | — | — | (F1) The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction. (F2) The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026. |
| 2 | Common | Common Stock | 2026-06-05 | S | D | 10,000 | $19.41 | 32,915 | D | — | — | (F1) The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction. (F2) The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026. |
| 3 | Common | Common Stock | 2026-06-05 | P | A | 6,000 | $19.48 | 38,915 | D | — | — | (F2) The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026. |
| 4 | Common | Common Stock | 2026-06-05 | P | A | 3,500 | $19.46 | 42,415 | D | — | — | (F2) The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026. |
| 5 | Common | Common Stock | 2026-06-05 | P | A | 1,000 | $19.27 | 43,415 | D | — | — | (F1) The sales by the reporting person reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934 with the purchase of 1,000 shares of the Issuer's common stock by the reporting person at the price of $19.27 per share on June 5, 2026. The reporting person has agreed to pay to the Issuer upon settlement of the sale, $155, representing the full amount of the profit realized in connection with the short-swing transaction. (F2) The reporting person sold and reacquired the same aggregate number of shares on June 5, 2026. |